- POC Testing
- Self-check kits
Anti-Müllerian Hormone Testing Market size was valued at USD 256.3 million in 2023 and is poised to grow at a 5.9% CAGR from 2024 to 2030. Anti-Müllerian hormone is produced by granulosa cells in ovarian follicles, serves as a reliable biomarker for ovarian function, and is widely used in fertility clinics and reproductive health centers. The anti-müllerian hormone testing market is experiencing significant growth due to the rising prevalence of infertility and reproductive disorders worldwide. Anti-müllerian hormone testing has emerged as a crucial tool in assessing ovarian reserve and predicting reproductive potential in women. The global anti-müllerian hormone testing market is driven by several factors, including the increasing incidence of polycystic ovary syndrome (PCOS), growing awareness about fertility preservation, and the rising average age of first-time mothers. According to recent statistics, PCOS affects approximately 8-13% of women of reproductive age globally, with rates varying across different populations. This prevalence has led to a surge in demand for anti-müllerian hormone testing as a diagnostic tool for PCOS and other reproductive disorders. Furthermore, the expanding field of assisted reproductive technologies (ART) has significantly contributed to market growth. In vitro fertilization (IVF) procedures have seen a steady increase. Since the pioneering success of IVF in 1978, the worldwide application of this reproductive technology has grown exponentially. In the four decades following that groundbreaking event, IVF has revolutionized fertility treatment, leading to the birth of approximately 8 million children globally through assisted pregnancies.
Anti-müllerian hormone testing plays a critical role in predicting ovarian response to stimulation in IVF treatments, making it an essential component of fertility assessments. The anti-müllerian hormone testing market is also benefiting from technological advancements in testing methods, with the development of more sensitive and automated assays. These innovations have improved the accuracy and reliability of anti-müllerian hormone measurements, further driving adoption in clinical settings. However, the market faces challenges such as limited reimbursement policies for anti-müllerian hormone testing in some regions and the potential for inconsistent results across different testing platforms. Despite these obstacles, the increasing focus on personalized medicine and the growing demand for non-invasive diagnostic tools are expected to propel the anti-müllerian hormone testing market forward. As research continues to uncover new applications for anti-müllerian hormone testing, including its potential role in predicting menopause onset and assessing certain ovarian cancers, the market is poised for continued expansion in the forecasted years.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The Anti-Müllerian Hormone Testing Market is primarily driven by the rising prevalence of polycystic ovary syndrome (PCOS) worldwide and the growing number of IVF and egg-freezing procedures. PCOS affects a significant portion of women of reproductive age, with recent studies indicating prevalence rates ranging from 6% to 26% depending on the diagnostic criteria used. This condition often leads to fertility issues, increasing the demand for anti-müllerian hormone testing as a diagnostic tool. Additionally, the surge in IVF procedures globally has boosted the market. According to the European Society of Human Reproduction and Embryology, there were over 918,000 treatment cycles reported in Europe in 2016, with a steady increase observed annually. Anti-Müllerian Hormone testing is crucial in predicting ovarian response to stimulation in IVF treatments, making it an integral part of fertility assessments and contributing significantly to market growth.
Anti-Müllerian Hormone Testing Market was valued at USD 256.3 million in 2023 and is expected to grow at a 5.9% CAGR from 2024 to 2030.
Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., bioMérieux S.A., Thermo Fisher Scientific Inc., and Siemens Healthineers AG are some of the major players operating in the anti-müllerian hormone testing market.
Asia Pacific is estimated to grow at the highest CAGR over the forecast period.
North America accounts for the largest market share and is expected to be the primary market driver in the anti-müllerian hormone testing market.
Limited reimbursement policies for anti-müllerian hormone testing in some regions and the potential for inconsistent results across different testing platforms are expected to limit the growth of the anti-müllerian hormone testing market.
1.Executive Summary |
2.Global Anti Müllerian Hormone Testing Market Introduction |
2.1.Global Anti Müllerian Hormone Testing Market - Taxonomy |
2.2.Global Anti Müllerian Hormone Testing Market - Definitions |
2.2.1.Product Type |
2.2.2.End User |
2.2.3.Application |
2.2.4.Region |
3.Global Anti Müllerian Hormone Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Anti Müllerian Hormone Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Anti Müllerian Hormone Testing Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. POC Testing |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Self-check kits |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Anti Müllerian Hormone Testing Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Hospitals |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Diagnostic Centers |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Fertility Clinics |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Research Laboratories |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global Anti Müllerian Hormone Testing Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Fertility Assessment |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. PCOS Diagnosis |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Ovarian Function Evaluation |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Menopause Prediction |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Others |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.Global Anti Müllerian Hormone Testing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Anti Müllerian Hormone Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.POC Testing |
9.1.2.Self-check kits |
9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Hospitals |
9.2.2.Diagnostic Centers |
9.2.3.Fertility Clinics |
9.2.4.Research Laboratories |
9.2.5.Others |
9.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Fertility Assessment |
9.3.2.PCOS Diagnosis |
9.3.3.Ovarian Function Evaluation |
9.3.4.Menopause Prediction |
9.3.5.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Anti Müllerian Hormone Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.POC Testing |
10.1.2.Self-check kits |
10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Hospitals |
10.2.2.Diagnostic Centers |
10.2.3.Fertility Clinics |
10.2.4.Research Laboratories |
10.2.5.Others |
10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Fertility Assessment |
10.3.2.PCOS Diagnosis |
10.3.3.Ovarian Function Evaluation |
10.3.4.Menopause Prediction |
10.3.5.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Anti Müllerian Hormone Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.POC Testing |
11.1.2.Self-check kits |
11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Hospitals |
11.2.2.Diagnostic Centers |
11.2.3.Fertility Clinics |
11.2.4.Research Laboratories |
11.2.5.Others |
11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Fertility Assessment |
11.3.2.PCOS Diagnosis |
11.3.3.Ovarian Function Evaluation |
11.3.4.Menopause Prediction |
11.3.5.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Anti Müllerian Hormone Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.POC Testing |
12.1.2.Self-check kits |
12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Hospitals |
12.2.2.Diagnostic Centers |
12.2.3.Fertility Clinics |
12.2.4.Research Laboratories |
12.2.5.Others |
12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Fertility Assessment |
12.3.2.PCOS Diagnosis |
12.3.3.Ovarian Function Evaluation |
12.3.4.Menopause Prediction |
12.3.5.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Anti Müllerian Hormone Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.POC Testing |
13.1.2.Self-check kits |
13.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Hospitals |
13.2.2.Diagnostic Centers |
13.2.3.Fertility Clinics |
13.2.4.Research Laboratories |
13.2.5.Others |
13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Fertility Assessment |
13.3.2.PCOS Diagnosis |
13.3.3.Ovarian Function Evaluation |
13.3.4.Menopause Prediction |
13.3.5.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Bio-Rad Laboratories, Inc. |
14.2.2.Beckman Coulter, Inc. |
14.2.3.bioMérieux S.A. |
14.2.4.Thermo Fisher Scientific Inc. |
14.2.5.Siemens Healthineers AG |
14.2.6.London Gynaecology Limited |
14.2.7.Monobind Inc |
14.2.8.Vitrosens Biotechnology Co., Ltd |
14.2.9.Cusabio Technology LLC |
14.2.10.Eagle Biosciences, Inc |
15. Research Methodology |
16. Appendix and Abbreviations |